Enasidenib (Standard)

Overview

Enasidenib (Standard) is the analytical standard of Enasidenib. This product is intended for research and analytical applications. Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes , with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isocitrate Dehydrogenase (IDH) | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-18690R
• CAS No.: 1446502-11-9
• Molecular Formula: C19H17F6N7O
• Molecular Weight: 473.38
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source